Neochem Bio Solutions IPO Opens Next Week with Price Band Set at Rs 93-98

November 26, 2025: The Initial Public Offer (IPO) of the Gujarat-based specialty chemicals manufacturer, Neochem Bio Solutions, will open on December 2, 2025. It will offer a fresh opportunity to the investor in the critical textile and garment washing auxiliaries segment. The subscription that opens next Tuesday will be open until December 4, 2025. This will be a book building issue of ₹44.97 crore, and the share will be listed on NSE SME Exchange (NSE Emerge Exchange).

Key IPO Details of Neochem Bio Solutions

As underlined, the total size of the issue will be close to ₹45 crore through a book-building process. The price band of the IPO is ₹93-98 per share, and the lot size of the application is 1200 shares. The company is offering 45.88 lakh shares through the IPO. The anchor book opens a day before the public subscription (Monday, December 1, 2025). The allotment will be carried out on December 5, and the listing is scheduled on December 9, 2025.

Use of Funds of Neochem Bio Solutions IPO

The company aims to use ₹23.90 crore for working capital requirements. Out of the remaining funds, around ₹10 crore will be used for paying outstanding borrowings, and the remaining is earmarked for general corporate purposes.

Business Overview of Neochem Bio Solutions

The company works in the critical specialty performance chemicals sector. It caters services to textile and garment washing, home and personal care, institutional and industrial cleaners, paint manufacturers, coating factors, dyes, and pigment manufacturers. The company operates a 22,000 metric ton per annum manufacturing facility located in Sanand, Gujarat.

Financial Performance of Neochem Bio Solutions IPO

The company has demonstrated some solid numbers in the recent past. For the first half of the current financial year, the company has posted a total revenue of ₹45.80 crore with a profit of ₹5.48 crore. In the previous year (FY 25), the company posted a revenue growth of 37.7% and a profit increase of 330.6% which reached ₹7.80 crore. Vivro Financial Services is managing the IPO.

This upcoming public issue positions Neochem Bio Solutions among the emerging players in the specialty chemicals space as it seeks capital to strengthen its growth trajectory.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations